Free Trial

Contineum Therapeutics (CTNM) Institutional Ownership

Contineum Therapeutics logo
$6.95 +0.20 (+2.96%)
Closing price 04:00 PM Eastern
Extended Trading
$6.94 -0.02 (-0.22%)
As of 05:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Contineum Therapeutics (NASDAQ:CTNM)

Number of
Institutional Buyers
(last 12 months)
37
Total
Institutional Inflows
(last 12 months)
$80.98M
Number of
Institutional Sellers
(last 12 months)
11
Total
Institutional Outflows
(last 12 months)
$15.45M
Get CTNM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Contineum Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

CTNM Institutional Buying and Selling by Quarter

Contineum Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/13/2025Marshall Wace LLP28,685$114K0.0%-7.7%0.111%
8/13/2025Saturn V Capital Management LP319,348$1.27M0.5%-43.1%1.234%
8/13/2025Norges Bank169,729$674K0.0%N/A0.656%
8/12/2025 Franklin Resources Inc.1,698,825$6.74M0.0%+7.8%6.567%
8/11/2025 Versant Venture Management LLC542,628$2.15M2.6%-40.9%2.098%
8/8/2025 Geode Capital Management LLC71,303$283K0.0%-63.1%0.276%
8/7/2025 Monaco Asset Management SAM75,000$298K0.1%N/A0.290%
8/1/2025 Y Intercept Hong Kong Ltd35,156$140K0.0%N/A0.136%
6/27/2025Goldman Sachs Group Inc.14,221$99K0.0%-46.1%0.055%
5/28/2025 Strs Ohio3,900$27K0.0%N/A0.015%
5/16/2025Goldman Sachs Group Inc.14,221$99K0.0%-46.1%0.055%
5/16/2025 Dynamic Technology Lab Private Ltd16,838$118K0.0%N/A0.065%
5/16/2025ADAR1 Capital Management LLC168,765$1.18M0.2%+105.2%0.652%
5/13/2025 Altium Capital Management LLC303,857$2.12M5.1%-9.0%1.174%
5/12/2025 Nuveen LLC13,307$93K0.0%N/A0.051%
5/9/2025 Charles Schwab Investment Management Inc.51,202$357K0.0%-7.5%0.198%
2/17/2025Squarepoint Ops LLC217,239$3.18M0.0%-37.9%0.843%
2/17/2025Stempoint Capital LP265,833$3.89M1.0%N/A1.031%
2/17/2025 Red Tree Management LLC638,158$9.35M6.2%N/A2.475%
2/17/2025Polar Capital Holdings Plc43,604$639K0.0%-79.9%0.169%
2/17/2025Nuveen Asset Management LLC13,307$195K0.0%N/A0.052%
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.5,860$86K0.0%+90.4%0.023%
2/17/2025Janus Henderson Group PLC68,320$1.00M0.0%N/A0.265%
2/17/2025 Deutsche Bank AG16,079$236K0.0%N/A0.062%
2/17/2025Bank of America Corp DE9,132$134K0.0%+63.4%0.035%
2/14/2025Schonfeld Strategic Advisors LLC125,995$1.85M0.0%N/A0.489%
2/14/2025Northern Trust Corp89,262$1.31M0.0%+42.3%0.346%
2/14/2025MetLife Investment Management LLC7,029$103K0.0%N/A0.027%
2/14/2025 Altium Capital Management LLC334,000$4.89M1.4%-9.5%1.296%
2/13/2025Marshall Wace LLP10,836$159K0.0%N/A0.042%
2/13/2025 Strategies Wealth Advisors LLC25,000$366K0.0%N/A0.097%
2/13/2025Barclays PLC16,286$239K0.0%+96.0%0.063%
2/13/2025 Legal & General Group Plc3,631$53K0.0%+74.0%0.014%
2/13/2025ADAR1 Capital Management LLC82,234$1.21M0.2%+817.1%0.319%
2/13/2025Wells Fargo & Company MN10,755$158K0.0%+419.3%0.042%
2/12/2025 Geode Capital Management LLC188,408$2.76M0.0%+46.4%0.731%
2/12/2025 Franklin Resources Inc.1,445,565$21.18M0.0%-0.1%5.607%
2/12/2025Norges Bank169,729$2.49M0.0%N/A0.658%
2/12/2025 JPMorgan Chase & Co.28,426$416K0.0%+1,040.7%0.110%
2/12/2025WINTON GROUP Ltd39,738$582K0.0%+256.8%0.154%
BREAKING: The House just passed 3 pro-crypto bills! (Ad)

THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here.

Discover the under-the-radar project I believe will skyrocket as a result.
2/11/2025 Corebridge Financial Inc.5,215$76K0.0%+73.1%0.020%
2/6/2025 Charles Schwab Investment Management Inc.55,330$811K0.0%+27.8%0.215%
2/4/2025 Bank of New York Mellon Corp18,738$275K0.0%+32.3%0.073%
1/30/2025 Rhumbline Advisers8,233$121K0.0%+36.3%0.032%
11/27/2024 Franklin Resources Inc.1,447,550$27.71M0.0%+130.9%5.615%
11/19/2024Barclays PLC8,308$158K0.0%+248.6%0.032%
11/16/2024 Geode Capital Management LLC128,676$2.46M0.0%-17.7%0.500%
11/15/2024Barclays PLC8,308$158K0.0%+248.6%0.032%
11/15/2024State Street Corp113,566$2.17M0.0%+23.7%0.442%
11/14/2024Suvretta Capital Management LLC1,720,000$32.92M1.1%-16.2%6.687%
11/13/2024BNP Paribas Financial Markets6,743$129K0.0%+1,248.6%0.026%
11/13/2024FMR LLC696,927$13.34M0.0%+115.4%2.710%
11/12/2024 Charles Schwab Investment Management Inc.43,295$829K0.0%-16.4%0.168%
8/16/2024Perceptive Advisors LLC1,566,668$27.59M0.7%N/A6.091%
8/16/2024Driehaus Capital Management LLC66,667$1.17M0.0%N/A0.259%
8/14/2024Squarepoint Ops LLC150,000$2.64M0.0%N/A0.583%
8/14/2024Sandia Investment Management LP5,000$88K0.1%N/A0.019%
8/9/2024 Johnson & Johnson1,979,173$34.85M8.7%N/A7.694%
8/8/2024 Versant Venture Management LLC918,163$16.17M20.9%N/A3.569%
8/1/2024 Rhumbline Advisers6,722$118K0.0%N/A0.026%
7/26/2024 Bank of New York Mellon Corp20,232$356K0.0%N/A0.079%
(Data available from 1/1/2016 forward)

CTNM Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CTNM shares?

During the previous two years, 44 institutional investors and hedge funds held shares of Contineum Therapeutics. The most heavily invested institutionals were Johnson & Johnson ($34.85M), Suvretta Capital Management LLC ($32.92M), Perceptive Advisors LLC ($27.59M), FMR LLC ($13.34M), Red Tree Management LLC ($9.35M), Franklin Resources Inc. ($6.74M), and Stempoint Capital LP ($3.89M).Learn more on Contineum Therapeutics' institutional investors.

Which institutional investors have been buying Contineum Therapeutics' stock?

Of the 39 institutional investors that purchased Contineum Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Johnson & Johnson ($1.98M), Perceptive Advisors LLC ($1.57M), Franklin Resources Inc. ($943.19K), Versant Venture Management LLC ($918.16K), Red Tree Management LLC ($638.16K), FMR LLC ($373.33K), and Norges Bank ($339.46K).

How much institutional buying is happening at Contineum Therapeutics?

Institutional investors have bought a total of 5,145,060 shares in the last 24 months. This purchase volume represents approximately $80.98M in transactions.

Which of Contineum Therapeutics' major shareholders have been selling company stock?

Of the 11 institutional investors that sold Contineum Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Versant Venture Management LLC ($375.54K), Suvretta Capital Management LLC ($333.33K), Saturn V Capital Management LP ($241.63K), Polar Capital Holdings Plc ($173.00K), Geode Capital Management LLC ($149.49K), Squarepoint Ops LLC ($132.76K), and Altium Capital Management LLC ($65.27K).

How much institutional selling is happening at Contineum Therapeutics?

Institutional investors have sold a total of 1,512,297 shares in the last 24 months. This volume of shares sold represents approximately $15.45M in transactions.



This page (NASDAQ:CTNM) was last updated on 8/13/2025 by MarketBeat.com Staff
From Our Partners